Systemic Tumor Embolism Mimicking Gefitinib ('IRESSA')-induced Interstitial Lung Disease in a Patient with Lung Cancer

DOI Web Site Web Site PubMed 被引用文献1件 参考文献18件
  • UMEMURA Shigeki
    Department of Hematology, Oncology and Respiratory Medicine Okayama University Graduate School of Medicine and Dentistry
  • KISHINO Daizo
    Department of Pulmonary Medicine, Okayama Institute of Health and Science
  • TABATA Masahiro
    Department of Hematology, Oncology and Respiratory Medicine Okayama University Graduate School of Medicine and Dentistry
  • KIURA Katsuyuki
    Department of Hematology, Oncology and Respiratory Medicine Okayama University Graduate School of Medicine and Dentistry
  • HOTTA Katsuyuki
    Department of Hematology, Oncology and Respiratory Medicine Okayama University Graduate School of Medicine and Dentistry
  • NISHII Kenji
    Department of Pulmonary Medicine, Okayama Institute of Health and Science
  • TANIMOTO Yasushi
    Department of Hematology, Oncology and Respiratory Medicine Okayama University Graduate School of Medicine and Dentistry
  • KANEHIRO Arihiko
    Department of Hematology, Oncology and Respiratory Medicine Okayama University Graduate School of Medicine and Dentistry
  • NOTOHARA Kenji
    Department of Pathology, Okayama University Graduate School of Medicine and Dentistry
  • UEOKA Hiroshi
    Department of Hematology, Oncology and Respiratory Medicine Okayama University Graduate School of Medicine and Dentistry
  • TANIMOTO Mitsune
    Department of Hematology, Oncology and Respiratory Medicine Okayama University Graduate School of Medicine and Dentistry

この論文をさがす

抄録

We describe a 55-year-old man with advanced adenocarcinoma of the lung who received gefitinib (‘IRESSA’). After gefitinib administration for 7 months, computed tomography scan of the chest demonstrated diffuse ground glass opacity and he was suspected to have developed gefitinib-induced interstitial lung disease (ILD). However, transbronchial lung biopsy (TBLB) revealed tumor cells in the middle-size lung vessels. Afterwards, multiple infarctions of the brain, spleen and left kidney were detected. Then, he was considered to have developed systemic tumor emboli, a rare complication. The clinical presentation of this patient was difficult to discriminate from that of ILD, and TBLB was useful in the differential diagnosis.

収録刊行物

  • Internal Medicine

    Internal Medicine 44 (9), 979-982, 2005

    一般社団法人 日本内科学会

被引用文献 (1)*注記

もっと見る

参考文献 (18)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ